OMC
FNCH

Oasis Management Company’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Oasis Management Company’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,500
Closed -$108K – 122
2022
Q4 		$108K Hold
7,500
– – 0.02% 100
2022
Q3 		$376K Hold
7,500
– – 0.06% 99
2022
Q2 		$639K Buy
+7,500
New +$641K 0.11% 75

Other funds holding FNCH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Oasis Management Company's FNCH Position: Q1 2023 in Review

Oasis Management Company sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q1 2023, closing a stake of 7,500 shares — an estimated $108K sold.

Oasis Management Company first reported a position in FNCH in Q2 2022 and held it in 3 quarters. The position peaked at $639K in Q2 2022. 33 funds tracked by Wall St. Rank hold FNCH as of Q1 2023.

  • Oasis Management Company reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 7,500 Finch Therapeutics Group, Inc. Common Stock shares in Q1 2023, an estimated $108K.
  • Oasis Management Company first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Finch Therapeutics Group, Inc. Common Stock position peaked at $639K in Q2 2022.
  • 33 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.